Skip to main content
LNTH
NASDAQ Life Sciences

FDA Delays Lantheus' LNTH-2501 Approval Over Third-Party Manufacturing Issues

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$109.8
Mkt Cap
$7.149B
52W Low
$47.25
52W High
$111.46
52W Position info
132% above low
Off High info
1.5% below high
Rel. Volume info
2.4× avg
Market data snapshot near publication time

LNTH has more than doubled off its 52-week low of $47.25 on elevated volume (2.4× avg).

Summary

The FDA issued a Complete Response Letter (CRL) for Lantheus' LNTH-2501, a PET diagnostic imaging kit for neuroendocrine tumors, delaying its approval past the June 29 PDUFA date. The CRL cited unresolved third-party manufacturing facility conditions, not concerns about the drug's clinical data, safety, or efficacy. This is a significant setback, pushing back potential market entry and revenue for a key pipeline product. Lantheus stated it is working with its partner and the FDA to address these manufacturing issues.

At the time of this announcement, LNTH was trading at $109.80 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $7.1B. The 52-week trading range was $47.25 to $111.46. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

LNTH - Latest Insights

LNTH
Nov 12, 2026, 4:34 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $101.25
Real-time Price: $102.10 info
Change: +$0.850 (+0.84%) info
Market Cap: $6.677B info
LNTH
Nov 09, 2026, 4:12 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $101.05
Real-time Price: $102.10 info
Change: +$1.05 (+1%) info
Market Cap: $6.677B info
LNTH
Nov 05, 2026, 11:24 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $100.97
Real-time Price: $102.10 info
Change: +$1.13 (+1%) info
Market Cap: $6.677B info
LNTH
Nov 05, 2026, 7:51 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $100.61
Real-time Price: $102.10 info
Change: +$1.49 (+1%) info
Market Cap: $6.677B info
LNTH
Nov 05, 2026, 7:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $100.61
Real-time Price: $102.10 info
Change: +$1.49 (+1%) info
Market Cap: $6.677B info